SBIR-STTR Award

Production of Transgenic Guinea Pigs
Award last edited on: 9/30/02

Sponsored Program
STTR
Awarding Agency
NIH : NCRR
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Karl M Ebert

Company Information

TranXenoGen

800 Boston Turnpike
Shrewsbury, MA 01545

Research Institution

----------

Phase I

Contract Number: 1R41RR013082-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$50,000
Description: The development of appropriate animal models is an important step in the study of any human disease and the development of therapies. The advent of transgenic and stem cell technology has provided researchers with a powerful tool to study many human diseases. This proposal is aimed at the application of transgenic technology to the guinea pig, a species that has not been previously targeted for transgenics. Transgenic guinea pig models will serve as invaluable research tools for the study of reproduction, infertility, neural peptide function, shock, and stroke. Commercially, the production of novel transgenic guinea pigs could be offered as a service, however, this research will develop transgenic guinea pigs carrying a human alpha estrogen receptor minigene. A transgenic guinea pig over-expressing the human estrogen receptor would serve as a valuable research model in many areas. The aim of this proposal is to characterize the expression pattern of the human ER gene and study its effect on the brain and reproductive organs of the guinea pig. Once characterized, the transgenic guinea pigs could be sold as research models to study the role of the estrogen receptor in tumorigenesis, the mechanism of tamoxifen resistance, reproductive aging, and estrogen's neuro protective effects.Proposed Commercial Application:Not avaliable

Thesaurus Terms:
biological model, estrogen receptor, guinea pig, model design /development, receptor expression, transgenic animal animal colonyNATIONAL CENTER FOR RESEARCH RESOURCES

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----